APOLLO ENDOSURGERY, INC. APEN Cash Flow

Apollo endosurgery, inc. (APEN)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net loss
-34,884	-27,432	-38,589	-39,690	-40,457	-45,787	-34,749	-29,892	-27,209	-27,292	-39,689	-40,720	-43,380	-41,167	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
3,911	4,060	5,376	6,757	8,038	9,292	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
3,911	4,060	5,376	6,757	8,038	9,292	9,481	9,527	9,676	9,717	9,605	9,584	9,416	9,092	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred financing costs
476	620	692	708	731	491	311	228	185	299	436	456	503	425	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest
0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest
-	-	-	-	-	-	-	-	403	595	9,915	10,596	11,856	13,317	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-49	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for doubtful accounts receivable
326	212	221	180	149	186	0	0	0	-	-	-	-	331	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory impairment
122	162	100	166	325	387	860	784	714	692	652	704	3,830	3,750	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14,029	-14,971	-16,026	-16,555	-11,599	-10,959	-8,615	-6,564	-6,811	-5,383	-4,648	-2,752	-5,070	-2,839	-820	-3,114	0	0	0
Stock based compensation
1,565	1,487	1,413	1,397	1,403	1,403	1,272	1,109	974	761	610	501	387	381	78	213	324	472	939	998	1,169	1,236	1,206	1,138	961	837	777	745	685	600	626	568	562	701	0	0	0
Unrealized foreign exchange on intercompany payables
-2,962	214	-1,205	-1,099	-628	-1,161	-1,305	-375	360	193	329	-366	-873	-1,332	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Settlement gain
0	5,609	5,609	5,609	5,609	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	1,350	1,200	2,900	1,100	2,600	4,200	600	0	0	0
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	311	259	250	216	201	166	190	196	273	269	208	187	151	151	142	141	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
-2,492	-1,852	-824	-45	-566	162	-1,586	-1,008	1,512	916	1,956	942	-1,184	426	-712	225	-1,031	-1,268	-2,002	-581	-1,261	-582	1,436	931	2,476	1,076	249	-260	-3,168	-1,100	-1,503	-226	1,237	-14,055	0	0	0
Inventory
148	-872	-1,523	-3,355	-3,708	-3,004	1,682	4,513	4,570	2,850	-309	-256	3,687	3,054	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other assets
-117	120	194	-154	99	-41	21	-563	-869	-948	-330	518	185	-327	-320	-505	-56	342	-1,467	-120	-14	120	1,400	223	228	-15	-25	65	28	-23	-153	33	65	165	0	0	0
Accounts payable and accrued expenses
-3,655	-2,052	1,840	4,020	82	-1,264	-1,567	-3,834	4,095	4,739	4,054	6,719	8,465	3,954	5,718	4,026	-2,032	512	-1,038	-535	-451	1,101	224	1,453	2,287	-179	235	-954	-1,712	-839	764	822	1,046	1,227	0	0	0
Net cash used in operating activities
-25,823	-25,622	-23,146	-19,631	-22,495	-23,119	-22,563	-23,999	-16,555	-13,320	-16,044	-13,701	-11,603	-12,901	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from investing activities:
Deferred contract revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-187	-250	-311	-373	-1,311	-3,093	-4,573	-5,336	-5,291	-4,506	-3,992	-3,782	-4,802	-4,524	-4,185	-4,258	0	0	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	30	27	26	24	21	13	16	41	30	-0	23	-48	11	-8	32	40	0	0	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-11,863	-15,524	-15,819	-15,186	-15,936	-13,113	-13,071	-13,149	-11,370	-10,984	-7,542	-8,313	-7,671	-8,106	-8,676	8,062	0	0	0
Purchases of property and equipment
965	805	452	838	890	1,951	2,271	2,008	2,484	1,564	1,662	1,502	862	1,028	5,365	5,313	5,160	4,763	27	27	35	105	105	105	124	44	37	100	146	154	159	128	141	134	0	0	0
Purchases of intangibles and other assets
156	175	357	623	875	930	908	650	516	573	763	857	1,147	1,337	2,805	2,681	2,307	2,019	327	380	410	430	383	357	370	346	311	267	216	189	227	385	365	354	0	0	0
Net cash used in investing activities
897	1,038	9,209	8,557	8,235	7,119	-3,179	-2,658	-3,000	-2,137	-2,225	-2,159	-1,809	-2,165	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities:
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-355	-407	-446	-535	-489	-463	-495	-391	-349	-368	-363	-344	-386	-513	-507	-489	0	0	0
Proceeds from sale of common stock and warrants, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21,237	0	0	0	-	-	-	-	19,078	0	0	0	-	-	-	-
Proceeds from exercise of stock options
28	31	11	58	638	738	738	760	201	119	127	63	35	53	120	111	116	123	47	47	45	0	12	12	14	15	0	0	0	-	-	-	-	34	0	0	0
Proceeds from long-term debt
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of deferred financing costs
1,934	2,857	2,784	1,268	1,176	400	353	353	353	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of long-term debt
0	21,668	31,668	34,168	34,168	12,500	2,500	0	0	7,000	18,220	18,220	18,220	11,220	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
18,094	30,506	20,559	-378	22,151	9,695	19,742	55,848	33,432	26,703	44,275	10,627	5,599	12,617	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash
-121	-8	-100	-64	-156	-106	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash, cash equivalents and restricted cash
-6,953	5,914	6,522	-11,516	7,735	-6,411	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash
-121	-8	-100	-64	-156	-106	-45	14	146	131	-44	-88	-48	-96	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash, cash equivalents and restricted cash
-6,953	5,914	6,522	-11,516	7,735	-6,411	-6,045	29,205	14,023	11,377	25,962	-5,321	-7,861	-2,545	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment for restricted stock tax liability on net settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	84	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,264	13,523	12,828	21,153	22,019	10,334	9,139	770	10,614	10,614	10,657	18,867	8,211	8,211	8,240	34	0	0	0
Net cash used in operating activities.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12,769	-1,105	-738	2,752	10,210	154	-407	-943	7,607	0	0	0
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-8,955	-2,409	-3,437	5,430	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of cash flow information:
Cash paid for interest
3,124	3,470	3,671	3,729	4,046	3,775	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	5,455	5,938	5,791	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for income taxes
335	328	194	88	84	98	132	279	270	274	0	0	0	-	-	-	-	49	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	0	0
Right-of-use assets recognized in exchange for new lease obligations (non-cash)
137	2,890	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of dividends on preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	9,040	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	1,350	1,200	2,900	1,100	2,600	4,200	600	0	0	0